LECT2 and metabolic dysfunction-associated steatotic liver disease: Leucocyte cell-derived chemotaxin-2 (LECT2) was first recognized as a chemotactic factor for neutrophils; however, it has also been implicated in NAFLD, skeletal muscle insulin sensitivity, and atherosclerosis as a hepatokine [20,21].